Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

在低收入和中等收入国家，对于患有镰状细胞病的儿童和青少年，低剂量羟基脲疗法可能与最大耐受剂量疗法具有相似的疗效。